clasto-Lactacystin β-lactone
SIGMA/L7035
Synonym: (1R,4R,5S)-1-[(1S)
CAS Number: 154226-60-5
Empirical Formula (Hill Notation): C10H15NO4
Molecular Weight: 213.23
MDL Number: MFCD01076526
Linear Formula: C10H15NO4
Product Type: Chemical
| assay | ≥95% (HPLC) |
| form | film |
| InChI | 1S/C10H15NO4/c1-4(2)6(12) |
| InChI key | FWPWHHUJACGNMZ-NBBQQVJHSA |
| Quality Level | 100 ![]() |
| SMILES string | [H][C@@]12OC(=O)[C@@]1(NC |
| solubility | DMSO: soluble 25 mg/mL |
| storage temp. | −20°C |
| Application: | Clasto-Lactacystin β-lactone has been used as a proteasomal inhibitor. |
| Application: | Clasto-Lactacystin β-lactone has been used as a protein degradation inhibitor to test its effect on memory improvements in mice. It has also been used as a proteasome inhibitor in human ovarian surface epithelium (HOSE) cells and dendritic cells (DCs). |
| Biochem/physiol Actions: | Cell-permeable and irreversible proteasome inhibitor. Lactacystin acts as a precursor for clasto-lactacystin β-lactone. |
| Biochem/physiol Actions: | Clasto-Lactacystin β-lactone (cLβL) is synthesized from lactacystin. It is cell-permeable and cLβL acts on the N-terminal threonine of subunit proteasome β -subunit X It also inhibits 20S proteasome activity in Haloferax volcanii by acting in the N-threonine residue of the β -type subunits. |
| Symbol | GHS07 |
| Signal word | Warning |
| Hazard statements | H319 |
| Precautionary statements | P264 - P280 - P305 + P351 + P338 - P337 + P313 |
| Hazard Codes | T |
| Risk Statements | 25-36/37/38 |
| Safety Statements | 26-45 |
| RIDADR | UN 2811 6.1 / PGIII |
| WGK Germany | WGK 2 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥95% (HPLC) |
| Storage Temp. | −20°C |
| UNSPSC | 12352200 |


